Conclusion
Owing to the difficulties health
services are encountering in dealing with the enormous challenge posed
by the COVID-19 pandemic, it is of strategic importance that vulnerable
groups such as pregnant women and newborns are not left by the wayside
and that quality research is promoted so that practical clinical
recommendations can be devised and implemented (22). In this critical
situation, ItOSS has been strategic, allowing data collection rapidly
thanks to the availability of a population-based network, consolidated
during the last 10 years to monitor maternal mortality and severe
morbidity in the country (23,24), and able to implement public health
surveillance and research. The preliminary results described in the
present study produced useful knowledge for clinical practice and
generated research questions that will find an answer in further studies
underway at international level. Our esteem and unconditional
recognition go to caregivers involved both in frontline assistance and
in the ItOSS research project, with whom we share the common goal of
gaining a more in-depth evaluation of the effects of SARS-CoV-2 on
mothers and newborns.